Klebsiella Pneumoniae Infection Clinical Trial
Official title:
Klebsiella Pneumoniae Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome
Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2018 |
Est. primary completion date | October 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - new confirmed community-onset or noscomial infection of Klebsiella pneumoniae infection Exclusion Criteria: - Age<18, or >85 years old; Mixed infection of Klebsiella pneumoniae and other microbes |
Country | Name | City | State |
---|---|---|---|
China | Sir Run Run Shaw Hospital | Hangzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Sir Run Run Shaw Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CRKP infection | Culture postitive results confirmed the infection of CRKP | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04413305 -
WGS-guided Tracking and Infection Control Measures of CRKP
|
N/A | |
Completed |
NCT04959344 -
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03245632 -
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
|
N/A | |
Recruiting |
NCT03891433 -
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
|
Phase 4 |